Could a new pill unlock better blood flow for stubborn chest pain?
NCT ID NCT06239974
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests whether the drug vericiguat can improve blood flow in the tiny vessels of the heart and reduce chest pain. About 94 adults aged 40-75 with stable chest pain but no major blockages will take the drug or a placebo. The main goal is to see if heart blood flow improves on special scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEST PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Hong Kong
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One blood test to rule out heart attacks?
- AI could sharpen emergency diagnoses for chest pain and breathing trouble
- Hands-On therapy may soothe cystic fibrosis pain without drugs
- New balloon trick may save heart muscle during heart attacks
- Sound wave scanner could help ER doctors spot heart trouble in minutes
- AI breakthrough could spot hidden heart attacks in patients with tricky ECG patterns